Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients
about
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral strokeRole of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopeniaRole of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.Autoimmune thrombocytopenias.Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.Pathobiology of secondary immune thrombocytopenia.Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopeniaCharacterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients.Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease.
P2860
Q24310892-49709AF8-FD88-4426-9672-0B2E3A609222Q27488342-0998244C-A636-43AA-ABD7-04910CCCB1DCQ31154319-E3288CA1-AFAA-4C74-A450-F7D633955EB5Q33332866-9E80899A-1A01-4FF7-930F-B0FD92FA06B1Q33360225-F6B7267F-6BFB-475D-BB5F-198C95BE227FQ33363539-3B0C99ED-AC56-4A86-8A82-877587CB78F5Q33375459-1A5670F9-6D51-45F4-A900-57353353BB15Q33383468-53235732-0D7C-4AAB-9681-AC1885E1BE0BQ33391806-091C48DA-24A0-4D68-8AA9-0F89142CE94BQ33401168-6A8C315B-29AF-4ED6-8A5F-330AD1040723Q33411216-F9FEA0AF-A0EF-4F7E-AC56-3203D3787E0CQ33499685-F4147E9A-7781-462E-9CDB-698C2C4D2BC1Q33504907-55DD6D59-B04C-479B-8F2F-8EE4363B6156Q34301163-8C052F04-BCF3-4DA4-8EF9-D61510E65C23
P2860
Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@ast
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@en
type
label
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@ast
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@en
prefLabel
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@ast
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@en
P2093
P2860
P356
P1476
Sequestration of anti-platelet ...... us 1 thrombocytopenic patients
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.6.2263
P407
P577
1995-03-01T00:00:00Z